Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

What Employer Actions Are Considered Most Important for the Return to Work of Employees with Cancer? A Delphi Study Among Employees and Employers.

Greidanus MA, Tamminga SJ, de Rijk AE, Frings-Dresen MHW, de Boer AGEM.

J Occup Rehabil. 2018 Jul 19. doi: 10.1007/s10926-018-9800-z. [Epub ahead of print]

PMID:
30027426
2.

Work-Related Outcomes in Self-Employed Cancer Survivors: A European Multi-country Study.

Torp S, Paraponaris A, Van Hoof E, Lindbohm ML, Tamminga SJ, Alleaume C, Van Campenhout N, Sharp L, de Boer AGEM.

J Occup Rehabil. 2018 Jun 26. doi: 10.1007/s10926-018-9792-8. [Epub ahead of print]

PMID:
29946813
3.

Employment status transitions in employees with and without chronic disease in the Netherlands.

de Boer AGEM, Geuskens GA, Bültmann U, Boot CRL, Wind H, Koppes LLJ, Frings-Dresen MHW.

Int J Public Health. 2018 Jul;63(6):713-722. doi: 10.1007/s00038-018-1120-8. Epub 2018 May 30.

4.

Higher incidence of screening-related cancers in the employed population.

Rottenberg Y, de Boer AGEM.

Occup Med (Lond). 2018 May 23;68(4):273-278. doi: 10.1093/occmed/kqy055.

PMID:
29635423
5.

The role of the general practitioner in return to work after cancer-a systematic review.

de Jong F, Frings-Dresen MH, Dijk NV, van Etten-Jamaludin FS, van Asselt KM, de Boer AGEM.

Fam Pract. 2018 Feb 6. doi: 10.1093/fampra/cmx114. [Epub ahead of print]

PMID:
29420712
6.

Wild, insectivorous bats might be carriers of Campylobacter spp.

Hazeleger WC, Jacobs-Reitsma WF, Lina PHC, de Boer AG, Bosch T, van Hoek AHAM, Beumer RR.

PLoS One. 2018 Jan 11;13(1):e0190647. doi: 10.1371/journal.pone.0190647. eCollection 2018.

7.

The quality of working life questionnaire for cancer survivors (QWLQ-CS): factorial structure, internal consistency, construct validity and reproducibility.

de Jong M, Tamminga SJ, van Es RJJ, Frings-Dresen MHW, de Boer AGEM.

BMC Cancer. 2018 Jan 10;18(1):66. doi: 10.1186/s12885-017-3966-1.

8.

Predictors for earlier return to work of cancer patients.

Wolvers MDJ, Leensen MCJ, Groeneveld IF, Frings-Dresen MHW, De Boer AGEM.

J Cancer Surviv. 2018 Apr;12(2):169-177. doi: 10.1007/s11764-017-0655-7. Epub 2017 Oct 26.

9.

Development of a tailored work-related support intervention for gastrointestinal cancer patients.

Zaman AGNM, Tytgat KMAJ, van Hezel S, Klinkenbijl JHG, de Boer AGEM, Frings-Dresen MHW.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12782. doi: 10.1111/ecc.12782. Epub 2017 Oct 12.

PMID:
29024185
10.

Cancer and its impact on work among the self-employed: A need to bridge the knowledge gap.

Sharp L, Torp S, Van Hoof E, de Boer AGEM.

Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12746. Epub 2017 Aug 8. Review.

PMID:
28786514
11.

Perceived employer-related barriers and facilitators for work participation of cancer survivors: A systematic review of employers' and survivors' perspectives.

Greidanus MA, de Boer AGEM, de Rijk AE, Tiedtke CM, Dierckx de Casterlé B, Frings-Dresen MHW, Tamminga SJ.

Psychooncology. 2018 Mar;27(3):725-733. doi: 10.1002/pon.4514. Epub 2017 Sep 6. Review.

PMID:
28753741
12.

Employers' experience of employees with cancer: trajectories of complex communication.

Tiedtke CM, Dierckx de Casterlé B, Frings-Dresen MHW, De Boer AGEM, Greidanus MA, Tamminga SJ, De Rijk AE.

J Cancer Surviv. 2017 Oct;11(5):562-577. doi: 10.1007/s11764-017-0626-z. Epub 2017 Jul 14.

13.

Return to work of cancer patients after a multidisciplinary intervention including occupational counselling and physical exercise in cancer patients: a prospective study in the Netherlands.

Leensen MCJ, Groeneveld IF, Heide IV, Rejda T, van Veldhoven PLJ, Berkel SV, Snoek A, Harten WV, Frings-Dresen MHW, de Boer AGEM.

BMJ Open. 2017 Jun 15;7(6):e014746. doi: 10.1136/bmjopen-2016-014746.

14.

Feasibility of a multidisciplinary intervention to help cancer patients return to work.

Leensen MCJ, Groeneveld IF, Rejda T, Groenenboom P, van Berkel S, Brandon T, de Boer AGEM, Frings-Dresen MHW.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12690. doi: 10.1111/ecc.12690. Epub 2017 Apr 25.

PMID:
28440572
15.

Adjustment between work demands and health needs: Development of the Work-Health Balance Questionnaire.

Gragnano A, Miglioretti M, Frings-Dresen MHW, de Boer AGEM.

Rehabil Psychol. 2017 Aug;62(3):374-386. doi: 10.1037/rep0000121. Epub 2017 Mar 20.

PMID:
28318280
16.

Quality of Working Life of cancer survivors: associations with health- and work-related variables.

de Jong M, Tamminga SJ, Frings-Dresen MH, de Boer AG.

Support Care Cancer. 2017 May;25(5):1475-1484. doi: 10.1007/s00520-016-3549-8. Epub 2016 Dec 26.

17.

Unemployment risk at 2 and 4 years following colorectal cancer diagnosis: a population based study.

Rottenberg Y, Ratzon NZ, Cohen M, Hubert A, Uziely B, de Boer AG.

Eur J Cancer. 2016 Dec;69:70-76. doi: 10.1016/j.ejca.2016.09.025. Epub 2016 Nov 4.

PMID:
27821321
18.
19.

Unemployment risk 2 years and 4 years following gastric cancer diagnosis: a population-based study.

Rottenberg Y, Jacobs JM, Ratzon NZ, Grinshpun A, Cohen M, Uziely B, de Boer AG.

J Cancer Surviv. 2017 Feb;11(1):119-125. doi: 10.1007/s11764-016-0568-x. Epub 2016 Aug 31.

PMID:
27582006
20.

Unemployment Risk and Decreased Income Two and Four Years After Thyroid Cancer Diagnosis: A Population-Based Study.

Ratzon NZ, Uziely B, de Boer AG, Rottenberg Y.

Thyroid. 2016 Sep;26(9):1251-8. doi: 10.1089/thy.2015.0608. Epub 2016 Aug 18.

PMID:
27400754
21.

Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.

De Boer AG, Bennebroek Evertsz' F, Stokkers PC, Bockting CL, Sanderman R, Hommes DW, Sprangers MA, Frings-Dresen MH.

Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1130-6. doi: 10.1097/MEG.0000000000000685.

PMID:
27340897
22.

Enhancing the Return to Work of Cancer Survivors: Development and Feasibility of the Nurse-Led eHealth Intervention Cancer@Work.

Tamminga SJ, van Hezel S, de Boer AG, Frings-Dresen MH.

JMIR Res Protoc. 2016 Jun 10;5(2):e118. doi: 10.2196/resprot.5565.

23.

The Quality of Working Life Questionnaire for Cancer Survivors (QWLQ-CS): a Pre-test Study.

de Jong M, Tamminga SJ, de Boer AG, Frings-Dresen MH.

BMC Health Serv Res. 2016 Jun 2;16:194. doi: 10.1186/s12913-016-1440-4.

24.

35P Unemployment risk among lung cancer survivors: A population based study.

Rottenberg Y, Uziely B, de Boer AG.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S70. doi: 10.1016/S1556-0864(16)30149-6. Epub 2016 Apr 15. No abstract available.

25.
26.

Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study.

Paalman CH, van Leeuwen FE, Aaronson NK, de Boer AG, van de Poll-Franse L, Oldenburg HS, Schaapveld M.

Br J Cancer. 2016 Jan 12;114(1):81-7. doi: 10.1038/bjc.2015.431.

27.

Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries.

Mewes JC, Steuten LM, Groeneveld IF, de Boer AG, Frings-Dresen MH, IJzerman MJ, van Harten WH.

BMC Cancer. 2015 Nov 12;15:899. doi: 10.1186/s12885-015-1912-7.

28.

Unemployment risk and income change after testicular cancer diagnosis: A population-based study.

Rottenberg Y, Ratzon NZ, Jacobs JM, Cohen M, Peretz T, de Boer AG.

Urol Oncol. 2016 Jan;34(1):5.e27-33. doi: 10.1016/j.urolonc.2015.08.016. Epub 2015 Oct 1.

PMID:
26427695
29.

Interventions to enhance return-to-work for cancer patients.

de Boer AG, Taskila TK, Tamminga SJ, Feuerstein M, Frings-Dresen MH, Verbeek JH.

Cochrane Database Syst Rev. 2015 Sep 25;(9):CD007569. doi: 10.1002/14651858.CD007569.pub3. Review.

PMID:
26405010
30.

Employment and insurance outcomes and factors associated with employment among long-term thyroid cancer survivors: a population-based study from the PROFILES registry.

Tamminga SJ, Bültmann U, Husson O, Kuijpens JL, Frings-Dresen MH, de Boer AG.

Qual Life Res. 2016 Apr;25(4):997-1005. doi: 10.1007/s11136-015-1135-z. Epub 2015 Sep 22.

31.

Quality of working life of cancer survivors: development of a cancer-specific questionnaire.

de Jong M, Tamminga SJ, de Boer AG, Frings-Dresen MH.

J Cancer Surviv. 2016 Apr;10(2):394-405. doi: 10.1007/s11764-015-0485-4. Epub 2015 Sep 14.

32.

Supporting cancer patients with work-related problems through an oncological occupational physician: a feasibility study.

Zaman ACGNM, Bruinvels DJ, de Boer AGEM, Frings-Dresen MHW.

Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12378. Epub 2015 Aug 31.

PMID:
26332251
33.

Molecular hazard identification of non-O157 Shiga toxin-producing Escherichia coli (STEC).

Franz E, van Hoek AH, Wuite M, van der Wal FJ, de Boer AG, Bouw EI, Aarts HJ.

PLoS One. 2015 Mar 19;10(3):e0120353. doi: 10.1371/journal.pone.0120353. eCollection 2015.

34.

A SpoT polymorphism correlates with chill stress survival and is prevalent in clinical isolates of Campylobacter jejuni.

Nierop Groot MN, de Boer AG, van Pelt W, van der Hulst-van Arkel MC, de Leeuw P, Widjaja HC, Smits MA, van der Wal FJ.

Poult Sci. 2014 Nov;93(11):2900-9. doi: 10.3382/ps.2014-04055. Epub 2014 Aug 29.

PMID:
25172931
35.

Comparative population structure analysis of Campylobacter jejuni from human and poultry origin in Bangladesh.

Islam Z, van Belkum A, Wagenaar JA, Cody AJ, de Boer AG, Sarker SK, Jacobs BC, Talukder KA, Endtz HP.

Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2173-81. doi: 10.1007/s10096-014-2184-x. Epub 2014 Jun 26.

PMID:
24962195
36.

Quality of working life issues of employees with a chronic physical disease: a systematic review.

de Jong M, de Boer AG, Tamminga SJ, Frings-Dresen MH.

J Occup Rehabil. 2015 Mar;25(1):182-96. doi: 10.1007/s10926-014-9517-6. Review.

PMID:
24832893
37.

A work-directed intervention to enhance the return to work of employees with cancer: a case study.

Tamminga SJ, Verbeek JH, de Boer AG, van der Bij RM, Frings-Dresen MH.

Work. 2013;46(4):477-85. doi: 10.3233/WOR-131681.

PMID:
24004741
38.

The European Cancer and Work Network: CANWON.

de Boer AG.

J Occup Rehabil. 2014 Sep;24(3):393-8. doi: 10.1007/s10926-013-9474-5.

PMID:
24002638
39.

Measurement properties of the Work Limitations Questionnaire were sufficient among cancer survivors.

Tamminga SJ, Verbeek JH, Frings-Dresen MH, De Boer AG.

Qual Life Res. 2014 Mar;23(2):515-25. doi: 10.1007/s11136-013-0484-8. Epub 2013 Jul 27.

PMID:
23893345
40.

Evaluation of molecular assays for identification Campylobacter fetus species and subspecies and development of a C. fetus specific real-time PCR assay.

van der Graaf-van Bloois L, van Bergen MA, van der Wal FJ, de Boer AG, Duim B, Schmidt T, Wagenaar JA.

J Microbiol Methods. 2013 Oct;95(1):93-7. doi: 10.1016/j.mimet.2013.06.005. Epub 2013 Jun 26.

PMID:
23810970
41.

Effectiveness of a hospital-based work support intervention for female cancer patients - a multi-centre randomised controlled trial.

Tamminga SJ, Verbeek JH, Bos MM, Fons G, Kitzen JJ, Plaisier PW, Frings-Dresen MH, de Boer AG.

PLoS One. 2013 May 22;8(5):e63271. doi: 10.1371/journal.pone.0063271. Print 2013.

42.

Work adjustments in a representative sample of employees with a chronic disease in the Netherlands.

Boot CR, van den Heuvel SG, Bültmann U, de Boer AG, Koppes LL, van der Beek AJ.

J Occup Rehabil. 2013 Jun;23(2):200-8. doi: 10.1007/s10926-013-9444-y.

PMID:
23592014
43.

Physical exercise and return to work: cancer survivors' experiences.

Groeneveld IF, de Boer AG, Frings-Dresen MH.

J Cancer Surviv. 2013 Jun;7(2):237-46. doi: 10.1007/s11764-012-0264-4. Epub 2013 Feb 27.

PMID:
23443319
44.

Practicalities of using non-local or non-recent multilocus sequence typing data for source attribution in space and time of human campylobacteriosis.

Smid JH, Mughini Gras L, de Boer AG, French NP, Havelaar AH, Wagenaar JA, van Pelt W.

PLoS One. 2013;8(2):e55029. doi: 10.1371/journal.pone.0055029. Epub 2013 Feb 6.

45.

The Coping with Attention and Memory Complaints Questionnaire (CAMQ): psychometric evaluation of an instrument in suspected chronic solvent-induced encephalopathy (CSE).

Visser I, de Boer AG, Wekking EM, van Vliet J, Van Hout MS, Schmand B, van der Laan G, Schene AH, van Dijk FJ.

Neuropsychol Rehabil. 2012;22(5):794-808.

PMID:
22992188
46.

A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.

Louwen R, Horst-Kreft D, de Boer AG, van der Graaf L, de Knegt G, Hamersma M, Heikema AP, Timms AR, Jacobs BC, Wagenaar JA, Endtz HP, van der Oost J, Wells JM, Nieuwenhuis EE, van Vliet AH, Willemsen PT, van Baarlen P, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):207-26. doi: 10.1007/s10096-012-1733-4. Epub 2012 Sep 4.

PMID:
22945471
47.

Risk factors for campylobacteriosis of chicken, ruminant, and environmental origin: a combined case-control and source attribution analysis.

Mughini Gras L, Smid JH, Wagenaar JA, de Boer AG, Havelaar AH, Friesema IH, French NP, Busani L, van Pelt W.

PLoS One. 2012;7(8):e42599. doi: 10.1371/journal.pone.0042599. Epub 2012 Aug 3.

48.

A multidisciplinary intervention to facilitate return to work in cancer patients: intervention protocol and design of a feasibility study.

Groeneveld IF, de Boer AG, Frings-Dresen MH.

BMJ Open. 2012 Jul 10;2(4). pii: e001321. doi: 10.1136/bmjopen-2012-001321. Print 2012.

49.

A hospital-based work support intervention to enhance the return to work of cancer patients: a process evaluation.

Tamminga SJ, de Boer AG, Bos MM, Fons G, Kitzen JJ, Plaisier PW, Verbeek JH, Frings-Dresen MH.

J Occup Rehabil. 2012 Dec;22(4):565-78. doi: 10.1007/s10926-012-9372-2.

50.

Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: a cross-sectional study.

de Boer AG, Bruinvels DJ, Tytgat KM, Schoorlemmer A, Klinkenbijl JH, Frings-Dresen MH.

BMJ Open. 2011 Dec 3;1(2):e000190. doi: 10.1136/bmjopen-2011-000190. Print 2011.

Supplemental Content

Loading ...
Support Center